Literature DB >> 7979624

Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy.

J Alvar1, R Molina, M San Andrés, M Tesouro, J Nieto, M Vitutia, F González, M D San Andrés, J Boggio, F Rodriguez.   

Abstract

Six naturally infected dogs [two with no signs of leishmaniasis ('asymptomatic'), two with a few signs ('oligosymptomatic') and two with many signs ('polysymptomatic')] were studied before and after chemotherapy. Another two, non-infected dogs were kept as controls. The dogs were studied clinically, haematologically and parasitologically five times over 11 months and their infectivity to sandflies was evaluated before and after the treatment. The 'asymptomatic' dogs were as infective to sandflies as the 'symptomatic' before treatment but all dogs were un-infective for at least a few months following chemotherapy. Treatment led to a temporary improvement in the clinical and biochemical condition of most of the dogs, the symptomatic dogs becoming asymptomatic, but parasitological cure was uncommon after 10 months' follow-up. There was often no correlation between clinical condition, parasitological condition and infectivity to sandflies. Some dogs from both the 'asymptomatic' and 'symptomatic' groups became infective to sandflies several months post-treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979624     DOI: 10.1080/00034983.1994.11812879

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  40 in total

1.  The effect of removing potentially infectious dogs on the numbers of canine Leishmania infantum infections in an endemic area with high transmission rates.

Authors:  Gabriel Grimaldi; Antonio Teva; Claudiney B Santos; Adelson L Ferreira; Aloísio Falqueto
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  Development of a dipstick assay for detection of Leishmania-specific canine antibodies.

Authors:  Henk D F H Schallig; Luís Cardoso; Marieke Hommers; Nel Kroon; Guus Belling; Manuela Rodrigues; Saul J Semião-Santos; Hans Vetter
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

3.  Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.

Authors:  E Carrillo; S Ahmed; K Goldsmith-Pestana; J Nieto; Y Osorio; B Travi; J Moreno; D McMahon-Pratt
Journal:  Vaccine       Date:  2006-11-10       Impact factor: 3.641

4.  Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate.

Authors:  Raul R Ribeiro; Eliane P Moura; Vitor M Pimentel; Weverton M Sampaio; Sydnei M Silva; Dante A Schettini; Cintia F Alves; Ferdinan A Melo; Wagner L Tafuri; Cynthia Demicheli; Maria N Melo; Frédéric Frézard; Marilene S M Michalick
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

5.  Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments.

Authors:  Guadalupe Miró; Rosa Gálvez; Cristeta Fraile; Miguel A Descalzo; Ricardo Molina
Journal:  Parasit Vectors       Date:  2011-04-13       Impact factor: 3.876

6.  Re-emergence of visceral and cutaneous leishmaniasis in the Greek Island of Crete.

Authors:  Vasiliki Christodoulou; Maria Antoniou; Pantelis Ntais; Ippokratis Messaritakis; Vladimir Ivovic; Jean-Pierre Dedet; Francine Pratlong; Vít Dvorak; Yiannis Tselentis
Journal:  Vector Borne Zoonotic Dis       Date:  2012-01-04       Impact factor: 2.133

7.  Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals.

Authors:  J Nieto; J Alvar; A B Mullen; K C Carter; C Rodríguez; M I San Andrés; M D San Andrés; A J Baillie; F González
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  Evaluation of a rapid device for serological diagnosis of Leishmania infantum infection in dogs as an alternative to immunofluorescence assay and Western blotting.

Authors:  E Ferroglio; S Zanet; W Mignone; M Poggi; A Trisciuoglio; P Bianciardi
Journal:  Clin Vaccine Immunol       Date:  2013-02-27

9.  Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis.

Authors:  J Moreno; J Nieto; S Masina; C Cañavate; I Cruz; C Chicharro; E Carrillo; S Napp; C Reymond; P M Kaye; D F Smith; N Fasel; J Alvar
Journal:  Vaccine       Date:  2007-06-04       Impact factor: 3.641

Review 10.  Control of visceral leishmaniasis in latin america-a systematic review.

Authors:  Gustavo A S Romero; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2010-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.